drugset / Trial / NCT00981747

Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis

NCT00981747

Phase 2/3 Terminated 12 enrolled Alicia Gerke Pulmonary Fibrosis Foundation · collab
NaSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether combination therapy with sildenafil and losartan can improve function and exercise tolerance in patients with idiopathic pulmonary fibrosis.

Timeline

Start
2009-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 25 mg
Subject Sildenafil Unknown 20 mg Oral